Dominique Lagadic‐Gossmann

7.1k total citations · 1 hit paper
130 papers, 5.7k citations indexed

About

Dominique Lagadic‐Gossmann is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Dominique Lagadic‐Gossmann has authored 130 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Molecular Biology, 25 papers in Cancer Research and 22 papers in Epidemiology. Recurrent topics in Dominique Lagadic‐Gossmann's work include Cell death mechanisms and regulation (17 papers), Liver Disease Diagnosis and Treatment (16 papers) and Carcinogens and Genotoxicity Assessment (14 papers). Dominique Lagadic‐Gossmann is often cited by papers focused on Cell death mechanisms and regulation (17 papers), Liver Disease Diagnosis and Treatment (16 papers) and Carcinogens and Genotoxicity Assessment (14 papers). Dominique Lagadic‐Gossmann collaborates with scholars based in France, Norway and United Kingdom. Dominique Lagadic‐Gossmann's co-authors include Richard D. Vaughan‐Jones, Odile Sergent, Marie‐Thérèse Dimanche‐Boitrel, Valérie Lecureur, Laurence Huc, Jørn A. Holme, Keith J. Buckler, Olivier Fardel, Xavier Tekpli and D. Feuvray and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Circulation Research.

In The Last Decade

Dominique Lagadic‐Gossmann

128 papers receiving 5.6k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Obesity I: Overview and molecular and biochemical mechanisms

2022 112 citations Étienne Blanc, Dominique Lagadic‐Gossmann et al. Biochemical Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dominique Lagadic‐Gossmann France	42	3.1k	827	679	601	597	130	5.7k
Michael A. Trush United States	48	4.8k 1.6×	763 0.9×	1.1k 1.6×	421 0.7×	720 1.2×	121	9.6k
Orazio Cantoni Italy	34	2.8k 0.9×	602 0.7×	684 1.0×	207 0.3×	376 0.6×	208	5.6k
Huiyong Yin China	57	4.8k 1.5×	330 0.4×	1.3k 1.9×	657 1.1×	408 0.7×	174	11.1k
Maik Hüttemann United States	50	5.4k 1.7×	335 0.4×	979 1.4×	231 0.4×	413 0.7×	154	8.7k
Michaël Thomas United States	40	2.0k 0.7×	263 0.3×	624 0.9×	287 0.5×	596 1.0×	166	5.4k
Young‐Mi Go United States	48	4.3k 1.4×	1.1k 1.3×	329 0.5×	268 0.4×	226 0.4×	143	8.0k
Noriko Noguchi Japan	57	4.1k 1.3×	257 0.3×	545 0.8×	301 0.5×	425 0.7×	187	10.0k
Ralf Morgenstern Sweden	50	4.7k 1.5×	381 0.5×	679 1.0×	175 0.3×	574 1.0×	171	8.2k
Phyllis A. Dennery United States	42	4.9k 1.6×	477 0.6×	533 0.8×	140 0.2×	327 0.5×	136	8.4k
Jing Zhang China	44	3.1k 1.0×	315 0.4×	625 0.9×	181 0.3×	610 1.0×	361	7.2k

Countries citing papers authored by Dominique Lagadic‐Gossmann

Since Specialization

Citations

This map shows the geographic impact of Dominique Lagadic‐Gossmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dominique Lagadic‐Gossmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dominique Lagadic‐Gossmann more than expected).

Fields of papers citing papers by Dominique Lagadic‐Gossmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dominique Lagadic‐Gossmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dominique Lagadic‐Gossmann. The network helps show where Dominique Lagadic‐Gossmann may publish in the future.

Co-authorship network of co-authors of Dominique Lagadic‐Gossmann

This figure shows the co-authorship network connecting the top 25 collaborators of Dominique Lagadic‐Gossmann. A scholar is included among the top collaborators of Dominique Lagadic‐Gossmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dominique Lagadic‐Gossmann. Dominique Lagadic‐Gossmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Morel, Chloé, Isabelle Gallais, Benoı̂t Pouyatos, et al.. (2025). Early stage of metabolic dysfunction associated steatotic liver disease disrupts circadian rhythm and induces neuroinflammation in rats. Scientific Reports. 15(1). 10616–10616. 2 indexed citations

Gallais, Isabelle, Isabelle Morel, Henri Schroeder, et al.. (2025). Key role of extracellular vesicles in the induction of necroptosis and apoptosis by a mixture of polycyclic aromatic hydrocarbons in the context of a steatohepatitis-like state. Toxicology. 516. 154184–154184.

Gall, Morgane Le, Franck Letourneur, Anne Maı̂tre, et al.. (2023). Small RNA-sequencing reveals the involvement of microRNA-132 in benzo[a]pyrene-induced toxicity in primary human blood cells. Environmental Pollution. 328. 121653–121653. 4 indexed citations

Rose, Sophie, Dominique Lagadic‐Gossmann, Xavier Coumoul, et al.. (2023). Assessment of endocrine disruptor impacts on lipid metabolism in a fatty acid-supplemented HepaRG human hepatic cell line. Chemosphere. 349. 140883–140883. 7 indexed citations

Monvoisin, Céline, et al.. (2023). A New In Vivo Zebrafish Bioassay Evaluating Liver Steatosis Identifies DDE as a Steatogenic Endocrine Disruptor, Partly through SCD1 Regulation. International Journal of Molecular Sciences. 24(4). 3942–3942. 14 indexed citations

Goff, Manon Le, Rémi Pradelles, Agnès Burel, et al.. (2019). Protective Action of Ostreococcus Tauri and Phaeodactylum Tricornutum Extracts towards Benzo[a]Pyrene-Induced Cytotoxicity in Endothelial Cells. Marine Drugs. 18(1). 3–3. 9 indexed citations

Goff, Manon Le, Dominique Lagadic‐Gossmann, Normand Podechard, et al.. (2019). PAHs increase the production of extracellular vesicles both in vitro in endothelial cells and in vivo in urines from rats. Environmental Pollution. 255. 113171–113171. 22 indexed citations

Goff, Manon Le, Eric Le Ferrec, Claire Mayer, et al.. (2019). Microalgal carotenoids and phytosterols regulate biochemical mechanisms involved in human health and disease prevention. Biochimie. 167. 106–118. 84 indexed citations

Lagadic‐Gossmann, Dominique, Kévin Hardonnière, Baharia Mograbi, Odile Sergent, & Laurence Huc. (2019). Disturbances in H+ dynamics during environmental carcinogenesis. Biochimie. 163. 171–183. 7 indexed citations

10.

Gallais, Isabelle, Muhammad Imran, Martine Chevanne, et al.. (2018). Mechanisms involved in the death of steatotic WIF-B9 hepatocytes co-exposed to benzo[a]pyrene and ethanol: a possible key role for xenobiotic metabolism and nitric oxide. Free Radical Biology and Medicine. 129. 323–337. 10 indexed citations

11.

Brinchmann, Bendik C., Eric Le Ferrec, William H. Bisson, et al.. (2018). Evidence of selective activation of aryl hydrocarbon receptor nongenomic calcium signaling by pyrene. Biochemical Pharmacology. 158. 1–12. 28 indexed citations

12.

Monet, Michaël, Mallorie Poët, Sébastien Tauzin, et al.. (2016). The cleaved FAS ligand activates the Na+/H+ exchanger NHE1 through Akt/ROCK1 to stimulate cell motility. Scientific Reports. 6(1). 28008–28008. 15 indexed citations

13.

Hardonnière, Kévin, Elise F. Saunier, Anthony Lemarié, et al.. (2016). The environmental carcinogen benzo[a]pyrene induces a Warburg-like metabolic reprogramming dependent on NHE1 and associated with cell survival. Scientific Reports. 6(1). 30776–30776. 55 indexed citations

14.

Podechard, Normand, Aurore Collin, Martine Chevanne, et al.. (2013). A role for lipid rafts in the protection afforded by docosahexaenoic acid against ethanol toxicity in primary rat hepatocytes. Food and Chemical Toxicology. 60. 286–296. 12 indexed citations

15.

Milosavljevic, Nina, Christophe Duranton, Nadir Djerbi, et al.. (2010). Nongenomic Effects of Cisplatin: Acute Inhibition of Mechanosensitive Transporters and Channels without Actin Remodeling. Cancer Research. 70(19). 7514–7522. 78 indexed citations

16.

Gilot, David, et al.. (2010). Akti-1/2, an allosteric inhibitor of Akt 1 and 2, efficiently inhibits CaMKIα activity and aryl hydrocarbon receptor pathway. Chemico-Biological Interactions. 188(3). 546–552. 20 indexed citations

17.

Landvik, Nina E., Volker M. Arlt, Eszter Nagy, et al.. (2009). 3-Nitrobenzanthrone and 3-aminobenzanthrone induce DNA damage and cell signalling in Hepa1c1c7 cells. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 684(1-2). 11–23. 27 indexed citations

18.

Huc, Laurence, Xavier Tekpli, Jørn A. Holme, et al.. (2007). c-Jun NH2-Terminal Kinase–Related Na+/H+ Exchanger Isoform 1 Activation Controls Hexokinase II Expression in Benzo( a )Pyrene-Induced Apoptosis. Cancer Research. 67(4). 1696–1705. 31 indexed citations

19.

Rébillard, Amélie, Xavier Tekpli, Olivier Meurette, et al.. (2007). Cisplatin-Induced Apoptosis Involves Membrane Fluidification via Inhibition of NHE1 in Human Colon Cancer Cells. Cancer Research. 67(16). 7865–7874. 131 indexed citations

20.

Gilot, David, Anne‐Laure Sérandour, Dominique Lagadic‐Gossmann, et al.. (2005). A role for caspase-8 and c-FLIP L in proliferation and cell-cycle progression of primary hepatocytes. Carcinogenesis. 26(12). 2086–2094. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact